SUSETTE GROSVELD: Open Payments
NPI 1912253576 · WHITTIER, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,498 in 64 payments from 10 companies in 2025. Trend: 2023 $427 · 2024 $1,205 · 2025 $1,498
Food & beverage: $1,414Education: $84
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 10 | $301 |
| Janssen Biotech, Inc. | 10 | $267 |
| Ardelyx, Inc. | 9 | $250 |
| Madrigal Pharmaceuticals | 21 | $245 |
| Phathom Pharmaceuticals, Inc. | 4 | $240 |
| ABBVIE INC. | 3 | $63 |
| Celltrion USA Inc. | 3 | $56 |
| Novo Nordisk Inc | 2 | $36 |
| Braintree Laboratories, Inc. | 1 | $24 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $16 |
Products named: DUPIXENT, TREMFYA, IBSRELA, REZDIFFRA, VOQUEZNA, VEGZELMA, LINZESS, Wegovy.
Industry payments across CA — which companies pay providers there.
